These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial. Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788 [TBL] [Abstract][Full Text] [Related]
5. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262 [TBL] [Abstract][Full Text] [Related]
7. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial. Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696 [TBL] [Abstract][Full Text] [Related]
8. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. ; Nasrallah IM; Pajewski NM; Auchus AP; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Doshi J; Erus G; Fine LJ; Gaussoin SA; Harris D; Johnson KC; Kimmel PL; Kurella Tamura M; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB; Williamson JD; Bryan RN JAMA; 2019 Aug; 322(6):524-534. PubMed ID: 31408137 [TBL] [Abstract][Full Text] [Related]
9. Association Between Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease: A Post Hoc Analysis of the SPRINT Randomized Clinical Trial. Frimodt-Møller EK; Vittinghoff E; Kaur G; Biering-Sørensen T; Soliman EZ; Marcus GM JAMA Cardiol; 2023 Jun; 8(6):612-616. PubMed ID: 37133829 [TBL] [Abstract][Full Text] [Related]
10. Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial. Nasrallah IM; Gaussoin SA; Pomponio R; Dolui S; Erus G; Wright CB; Launer LJ; Detre JA; Wolk DA; Davatzikos C; Williamson JD; Pajewski NM; Bryan RN; JAMA Neurol; 2021 May; 78(5):568-577. PubMed ID: 33683313 [TBL] [Abstract][Full Text] [Related]
11. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803 [TBL] [Abstract][Full Text] [Related]
12. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial. Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922 [TBL] [Abstract][Full Text] [Related]
13. Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. Rashid T; Li K; Toledo JB; Nasrallah I; Pajewski NM; Dolui S; Detre J; Wolk DA; Liu H; Heckbert SR; Bryan RN; Williamson J; Davatzikos C; Seshadri S; Launer LJ; Habes M JAMA Netw Open; 2023 Mar; 6(3):e231055. PubMed ID: 36857053 [TBL] [Abstract][Full Text] [Related]
14. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial. Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM; JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324 [TBL] [Abstract][Full Text] [Related]
15. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813 [TBL] [Abstract][Full Text] [Related]
16. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial. Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM; Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800 [TBL] [Abstract][Full Text] [Related]
17. Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice. Drawz PE; Agarwal A; Dwyer JP; Horwitz E; Lash J; Lenoir K; McWilliams A; Oparil S; Rahbari-Oskoui F; Rahman M; Parkulo MA; Pemu P; Raj DS; Rocco M; Soman S; Thomas G; Tuot DS; Whelton PK; Pajewski NM JAMA Intern Med; 2020 Dec; 180(12):1655-1663. PubMed ID: 33044494 [TBL] [Abstract][Full Text] [Related]
18. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial. Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Effect of Home Blood Pressure Self-Monitoring Plus Medication Self-Titration for Patients With Hypertension: A Secondary Analysis of the ADAMPA Randomized Clinical Trial. Martínez-Ibáñez P; Marco-Moreno I; García-Sempere A; Peiró S; Martínez-Ibáñez L; Barreira-Franch I; Bellot-Pujalte L; Avelino-Hidalgo E; Escrig-Veses M; Bóveda-García M; Calleja-Del-Ser M; Robles-Cabaniñas C; Hurtado I; Rodríguez-Bernal CL; Giménez-Loreiro M; Sanfélix-Gimeno G; Sanfélix-Genovés J; JAMA Netw Open; 2024 May; 7(5):e2410063. PubMed ID: 38728033 [TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial. Margolis KL; Asche SE; Dehmer SP; Bergdall AR; Green BB; Sperl-Hillen JM; Nyboer RA; Pawloski PA; Maciosek MV; Trower NK; O'Connor PJ JAMA Netw Open; 2018 Sep; 1(5):e181617. PubMed ID: 30646139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]